Search

Objectives: Patient-reported outcome measures (PROMs) have emerged as a promising approach to involve patients in their treatment process. Beyond serving as outcome measures, PROMs can be applied to provide feedback to healthcare providers and patients, thereby offering valuable insights that can improve health outcomes and care processes. This overview offers a comprehensive synthesis of the effects of PROM feedback, contributing to the evidence-based discussion on PROMs' potential to enhance patient care., Methods: Following Cochrane Collaboration recommendations, this overview included literature reviews across diverse treatment areas, investigating the impact of PROM feedback on patient health outcomes (including quality of life, symptoms, or survival) and care process outcomes (including communication, symptom identification, or clinical practice). The methodological quality of the evidence was assessed with a modified version of A Measurement Tool to Assess Systematic Reviews 2, and the potential overlap of primary studies was quantified. Results were narratively synthesized., Results: Forty reviews grouped into 4 categories of treatment areas were included. Overall, their methodological quality was low. The overall overlap of primary studies was 2.2%, reaching up to 15.7% within specific treatment areas. The results indicate that PROM feedback may enhance the quality-of-care processes, whereas its effects on patient health outcomes remained less conclusive., Conclusions: PROM feedback positively influences the interaction between physicians and patients across the included treatment areas. Further research is needed to comprehend the trickle-down effects of PROM feedback and how to enhance its potential in yielding health benefits for patients., Competing Interests: Author Disclosures Author disclosure forms can be accessed below in the Supplemental Material section., (Copyright © 2024. Published by Elsevier Inc.)

Eighty osteoarthritic female patients were randomly allocated to 4 equal groups; the Zwey-Muller, the Corail, the Optifix, or Autophor 900S cementless total hip arthroplasties (THAs) were implanted; and bone density changes, at different sites, were prospectively studied. In zone 7, the greatest reduction of bone density values was observed at 2 years (group A: 24%, group B: 8%, group C: 14.8%, and group D: 18.5%). In all groups, a similar pattern of slow but progressive recovery of bone mineral density changes after the third year was observed, approaching baseline values at 10 years, during which all patients showed satisfactory clinical results. We suggest that the clinical and theoretical relevance of the stress-shielding phenomenon in THA has been overestimated in the literature.